Guilin Sanjin (002275.SZ) recently stated during a reception for institutional investors that the company mainly produces dual-use drugs, with varying proportions for each type. Overall, OTC drugs are the main focus, while prescription drugs are a secondary focus, accounting for approximately 80% and 20%, respectively. For the Watermelon Frost series, the proportion of OTC drugs is always higher than prescription drugs, approximately 80% to 20%, while the hospital usage of Sanjin Tablets is slightly higher than Watermelon Frost.
桂林三金(002275.SZ)：三金片的院内的占比要略高于西瓜霜
Guilin Sanjin Pharmaceutical (002275.SZ): The proportion of Sanjin Pills in the hospital is slightly higher than that of Xigua Frost.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.